ClavystBio and A*STAR Partner to Grow MedTech Ventures in Singapore
Jun 10, 2025
Singapore, June 10: ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to create and grow MedTech ventures in Singapore. This partnership will support venture creation, product development, and commercialisation by bringing together ClavystBio and two national initiatives hosted by A*STAR -- MedTech Catapult and the Diagnostics Development Hub (DxD Hub) -- along with A*STAR's broader MedTech and venture creation capabilities.
Read More...
